| Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors JJ Luke, JM Lemons, TG Karrison, SP Pitroda, JM Melotek, Y Zha, ... Journal of Clinical Oncology 36 (16), 1611-1618, 2018 | 557 | 2018 |
| Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis SP Pitroda, NN Khodarev, L Huang, A Uppal, SC Wightman, S Ganai, ... Nature communications 9 (1), 1793, 2018 | 247 | 2018 |
| Tumor-reprogrammed resident T cells resist radiation to control tumors A Arina, M Beckett, C Fernandez, W Zheng, S Pitroda, SJ Chmura, ... Nature communications 10 (1), 3959, 2019 | 207 | 2019 |
| STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect SP Pitroda, BT Wakim, RF Sood, MG Beveridge, MA Beckett, ... BMC medicine 7, 1-10, 2009 | 193 | 2009 |
| Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs DRE Ranoa, AD Parekh, SP Pitroda, X Huang, T Darga, AC Wong, ... Oncotarget 7 (18), 26496, 2016 | 187 | 2016 |
| MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer NN Khodarev, SP Pitroda, MA Beckett, DM MacDermed, L Huang, ... Cancer research 69 (7), 2833-2837, 2009 | 145 | 2009 |
| STAT1 pathway mediates amplification of metastatic potential and resistance to therapy NN Khodarev, P Roach, SP Pitroda, DW Golden, M Bhayani, MY Shao, ... PloS one 4 (6), e5821, 2009 | 139 | 2009 |
| Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome SC Wightman, A Uppal, SP Pitroda, S Ganai, B Burnette, M Stack, ... British journal of cancer 113 (2), 327-335, 2015 | 138 | 2015 |
| MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer Y Yasumizu, H Rajabi, C Jin, T Hata, S Pitroda, MD Long, M Hagiwara, ... Nature communications 11 (1), 338, 2020 | 135 | 2020 |
| Clinical and molecular markers of long‐term survival after oligometastasis‐directed stereotactic body radiotherapy (SBRT) AC Wong, SP Watson, SP Pitroda, CH Son, LC Das, ME Stack, A Uppal, ... Cancer 122 (14), 2242-2250, 2016 | 131 | 2016 |
| MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment SP Pitroda, NN Khodarev, MA Beckett, DW Kufe, RR Weichselbaum Proceedings of the National Academy of Sciences 106 (14), 5837-5841, 2009 | 131 | 2009 |
| Integration of radiotherapy and immunotherapy for treatment of oligometastases SP Pitroda, SJ Chmura, RR Weichselbaum The Lancet Oncology 20 (8), e434-e442, 2019 | 126 | 2019 |
| 14q32-encoded microRNAs mediate an oligometastatic phenotype A Uppal, SC Wightman, S Mallon, G Oshima, SP Pitroda, Q Zhang, ... Oncotarget 6 (6), 3540, 2015 | 119 | 2015 |
| Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer N Khodarev, R Ahmad, H Rajabi, S Pitroda, T Kufe, C McClary, MD Joshi, ... Oncogene 29 (6), 920-929, 2010 | 117 | 2010 |
| Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging SL Liauw, SP Pitroda, SE Eggener, WM Stadler, CA Pelizzari, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 378-384, 2013 | 112 | 2013 |
| DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy SP Pitroda, IM Pashtan, HL Logan, B Budke, TE Darga, ... Science translational medicine 6 (229), 229ra42-229ra42, 2014 | 106 | 2014 |
| MUC1-C activates the TAK1 inflammatory pathway in colon cancer H Takahashi, C Jin, H Rajabi, S Pitroda, M Alam, R Ahmad, D Raina, ... Oncogene 34 (40), 5187-5197, 2015 | 100 | 2015 |
| Oligometastatic prostate cancer: reality or figment of imagination? CC Foster, RR Weichselbaum, SP Pitroda Cancer 125 (3), 340-352, 2019 | 97 | 2019 |
| Radiotherapy and immunotherapy: open questions and future strategies KB Pointer, SP Pitroda, RR Weichselbaum Trends in cancer 8 (1), 9-20, 2022 | 96 | 2022 |
| RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation RC Widau, AD Parekh, MC Ranck, DW Golden, KA Kumar, RF Sood, ... Proceedings of the National Academy of Sciences 111 (4), E484-E491, 2014 | 91 | 2014 |
ralph weichselbaumprofessor radiation oncology university of chicagoVerified email at radonc.uchicago.edu